BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification BREAKING: The FDA just made it official. Advisory committee meetings are now scheduled for July 23 24 to review reclassifying peptides back to legal compounding status. Here's what's happening: After the The FDA's Ban of Therapeutic Peptides: A Threat to Health Freedom Slim 'n Sleek RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea